PLUMP ANDREW STEWART (President, R&D) sold 44.4% of their position (116.19K shares) of TAKEDA PHARMACEUTICAL CO LTD on the open market
Open‑market sale worth $2.15M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/4/2026ACC: 0001395064-26-000335
DirectorOfficer· President, R&D
Since Mar 2026
-116.19K
Net shares
Net seller
$2.15M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
116.19K disposed
Non-Derivative Transactions1
American Depositary Shares
Indirect
Shares
−116.19K
Price / share
$18.49
Trade value
$2.15M
% of position
44.4%
9/2/2026
261.66K→145.47K
Total
Net shares
−116.19K
Net value
-$2.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Indirect | 9/2/2026 | S · Sale | −116.19K | $18.49 | $2.15M | 44.4% | 261.66K | 145.47K |
| Total | −116.19K | -$2.15M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
American Depositary Shares
DirectShares owned766.57K
Total
766.57K direct766.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares | 766.57K | Direct |
| Total | 766.57K | 766.57K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported